GLOW
Also known as GLOW Stack
Quick facts
- Researched for
- Smoother, brighter or firmer-looking skin and recovery
- Route or form
- InjectionGLOW 70 mg: GHK-Cu 50 mg, BPC-157 10 mg and TB-500 fragment 10 mg
- Evidence so far
- Only community reports; no study has tested the blend or shown that it's safe.
- Not established
- Studies of single ingredients do not prove what the injected blend does.
- Commonly researched
- About 2.8 to 3.5 mg of the blend, once dailyCommunity reportsSee every range
- Where to get it
- At our partner, US Precision Peptides.Go to Next step
By the Learn Peptides editorial team · Updated · How We Research
What people are researching it for
People are researching GLOW for smoother, brighter, or firmer-looking skin and for recovery.
Repair. Rejuvenate. Recover.
- What is the GLOW Stack?
- Vial illustrations: GHK-Cu 50 mg / BPC-157 10 mg / TB-500 10 mg, each labelled "Research Use Only"
- Checklist: Not an FDA-approved drug
- typically combines three research peptides
- How does it work?
- Sections: GHK-Cu; BPC-157; TB-500
- Common research use cases
- Not written out in this text version.
- How it's used in research
- Route: Subcutaneous (most common)
- Route: Local (near injury)
- Common blend: GHK-Cu: 50 mg
- Common blend: BPC-157: 10 mg
- Common blend: TB-500: 10 mg
- Common blend: (Variations are common)
- Typical duration: 4 to 8 weeks (common initial period)
- Typical duration: Some run longer based on goals
- There is no standardized dose or protocol. Research use should be thoughtful, tracked, and adjusted based on individual response.
- What users report
- Keep in mind: Results vary widely
- Keep in mind: Not everyone responds
- Keep in mind: May help with symptoms, but long-term effects are still unknown
- Key takeaway
- It's not a magic solution, but it has real potential and is one of the most discussed peptide combinations for a reason.
- The bottom line
- The GLOW Stack shows strong potential for skin, hair, collagen, and recovery support, but more high-quality human studies are needed. Use only high-purity peptides, follow a research-focused approach, and set realistic expectations.
Reasons people look into GLOW. An interest is not a promise that it works.
- Skin, hair & tanning
- Injury & recovery
People report better skin and less joint pain, but burning where it's injected is common.
Community reports
People often report smoother, brighter, or firmer-looking skin over time, along with easier recovery or less tendon, ligament, or joint discomfort.
GLOW is a community-named of three peptides (GHK-Cu, BPC-157 and a TB-500-type ingredient) that people look at for better-looking skin and for recovery from nagging soft-tissue injuries.
What this is based on
- Community reportsWhat people describe noticing. Not proof of cause.
- Learn Peptides explanationOur own plain-English summary of the sources. It is not a source itself.
Community reports
People mainly use GLOW for better-looking skin and for recovery from old tendon, ligament and joint problems, and skin changes are the most consistent positive report. Reports split: a minority notice nothing at all, and burning, redness and lumps where it is injected are the most common complaint.
The studies are on the single ingredients, not on the GLOW blend itself.
The science comes from the separate ingredients, especially GHK-Cu skin research and early BPC-157 and thymosin-related recovery research.
Studies of single ingredients do not prove what the injected blend does.
Ingredient evidence does not prove the effect of the finished injectable .
Safety notes
Nobody has studied this . Burning, redness and lumps where it is injected are the most common complaint, and the mix changes from seller to seller.
- You have trouble breathing or wheezing, or your face, lips, tongue or throat swell.
- You get hives away from the injection site, or feel severely dizzy or faint.
For these signs, call 911 or your local emergency number.
- Redness spreads, or heat, swelling or pain keeps growing where you injected.
- A lump keeps growing or does not go away, or you see pus or red streaks.
- You have a fever or chills, or feel sick all over.
- Wilson's disease or another copper-handling condition. It contains GHK-Cu, which delivers copper. People with Wilson's disease cannot clear copper.
- Cancer, now or in the past. It contains BPC-157 and TB-500. BPC-157 helps grow new blood vessels, and studies link the protein TB-500 comes from to tumor spread. Talk to your oncologist first.
- Anxiety, panic, bipolar or another mood condition. Some people using this report anxiety or unusual sensations. It contains BPC-157, and some people using BPC-157 report flat mood or anxiety that went away after stopping.
- Burning, stinging, redness, bruising, hard lumps and painful welts at the injection site are the most common complaint, and some people stop because of them.
- There is no standard GLOW formula. The amount of each ingredient changes from seller to seller, so two products with this name may not be the same.
- Because the three ingredients are premixed, it is hard to tell which one is responsible if you have a reaction, and you cannot lower one without lowering the others.
- The TB-500 named on a label may not be the same material as the thymosin beta-4 used in most published research.
- Some people report nausea, dizziness, diarrhea, headache or tiredness while using the .
- Nobody has tested this in a controlled human study, so both its benefits and its risks are unproven.
- The safety of the is unknown. What is known about side effects comes from anonymous online reports, which our research review calls unreliable, and our research review's own sources were not re-checked when it was archived.
Questions to bring to your doctor
Only for the conditions this page cautions about. Bring this page with you.
- I have or had cancer. Should I avoid GLOW, and what would you watch for?
- What mood changes on GLOW should make me stop and call you?
- Does my copper condition rule out GLOW?
Shows the blend amount people report and what it equals per ingredient.
Commonly researched ranges, and how they were measured.
Commonly researched range for GLOW
About 2.8 to 3.5 mg of the blend
once daily · Injection
Typical schedule: 4 to 8 weeks
Community reports
For the 70 mg vial (GHK-Cu 50 mg, BPC-157 10 mg, TB-500 fragment 10 mg), that is about GHK-Cu 2 to 2.5 mg, BPC-157 400 to 500 mcg and TB-500 fragment 400 to 500 mcg. No clinical trial has tested the blend itself.
From our visual summary
Community reports
Community reports, from the Learn Peptides visual summary. These lines sit beside the ranges above and are not merged with them.
- Common blend
- GHK-Cu: 50 mg
- BPC-157: 10 mg
- TB-500: 10 mg
- (Variations are common)
- Typical duration
- 4 to 8 weeks (common initial period)
- Some run longer based on goals
There is no standard dose. Track how you respond, and change one thing at a time.
Check your syringe math with your own numbers.
A blend of GHK-Cu, BPC-157 and a TB-500-type ingredient, with no standard formula.
GLOW is not a single compound. It is a of three peptides: GHK-Cu, BPC-157 and a TB-500-type ingredient, often discussed as one premixed vial. The name comes from peptide forums and sellers, there is no standard medical formula, and the amount of each ingredient changes from seller to seller. In the reports we reviewed, people mostly take it by injection.
Not the same as
- GLOW is not KLOW. Forums describe KLOW as the three GLOW ingredients plus a fourth peptide, KPV. It is a separate blend and reports about one should not be read as reports about the other.
- GLOW is not the Wolverine stack. Forums use Wolverine for BPC-157 plus TB-500 without GHK-Cu, and talk about it mainly for injuries.
- GLOW is not the same as GHK-Cu, BPC-157 or TB-500 taken alone. Studies and reports about one ingredient are not studies or reports about the blend.
- GLOW is a forum and seller name, not a standard medicine. Our research review says there is no standardized pharmaceutical formulation called GLOW.
- Forums use TB-500, TB4 and thymosin beta-4 as if they were the same thing. Our research review says they are not, and that most research is about full-length thymosin beta-4 rather than TB-500.
- People on forums disagree over whether an earlier, forum-popularized GHK-Cu plus BPC-157 protocol (later commonly used with TB-500 added) should count as the same thing as GLOW.
Next step
US Precision Peptides
GLOW 70 mg
GHK-Cu 50 mg + BPC-157 10 mg + TB-500 fragment 10 mg
This is a blend.
About product links
Purchases at US Precision Peptides help keep Learn Peptides free.